ProfileGDS4718 / 229730_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 42% 47% 35% 39% 55% 37% 45% 37% 42% 40% 33% 47% 48% 48% 41% 40% 63% 47% 41% 43% 42% 41% 42% 43% 55% 33% 71% 46% 47% 44% 43% 38% 37% 43% 56% 46% 39% 41% 58% 34% 45% 41% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.812936
GSM549102patient 115, normal, homogenized [OPG study]5.1365542
GSM549104patient 119, normal, homogenized [OPG study]5.3147647
GSM549108patient 138, normal, homogenized [OPG study]4.7926235
GSM549119patient 077, normal, homogenized [OPG study]4.9677839
GSM549133patient 032, cancer, homogenized [OPG study]5.7861155
GSM549139patient 042, cancer, homogenized [OPG study]4.8478937
GSM549099patient 107, normal, homogenized [OPG study]5.260545
GSM549109patient 139, normal, homogenized [OPG study]4.8905637
GSM549110patient 046, normal, homogenized [OPG study]5.1135742
GSM549114patient 063, normal, homogenized [OPG study]4.9377840
GSM549122patient 082, normal, homogenized [OPG study]4.6860833
GSM549134patient 033, cancer, homogenized [OPG study]5.3416847
GSM549136patient 036, cancer, homogenized [OPG study]5.3596148
GSM549140patient 044, cancer, homogenized [OPG study]5.3884748
GSM549111patient 047, normal, homogenized [OPG study]5.0017541
GSM549113patient 057, normal, homogenized [OPG study]4.9563140
GSM549132patient 031, cancer, homogenized [OPG study]6.3488463
GSM549137patient 038, cancer, homogenized [OPG study]5.3251447
GSM549142patient 047, cancer, homogenized [OPG study]5.147141
GSM549100patient 110, normal, homogenized [OPG study]5.1455243
GSM549107patient 135, normal, homogenized [OPG study]5.0640942
GSM549115patient 068, normal, homogenized [OPG study]4.9846641
GSM549116patient 072, normal, homogenized [OPG study]5.0553142
GSM549120patient 078, normal, homogenized [OPG study]5.1374443
GSM549131patient 030, cancer, homogenized [OPG study]5.759255
GSM549118patient 074, normal, homogenized [OPG study]4.6821333
GSM549129patient 027, cancer, homogenized [OPG study]6.9935971
GSM549123patient 088, normal, homogenized [OPG study]5.291446
GSM549124patient 006, cancer, homogenized [OPG study]5.3541747
GSM549126patient 015, cancer, homogenized [OPG study]5.1608644
GSM549128patient 025, cancer, homogenized [OPG study]5.1113943
GSM549103patient 117, normal, homogenized [OPG study]4.9801138
GSM549117patient 073, normal, homogenized [OPG study]4.8225837
GSM549138patient 041, cancer, homogenized [OPG study]5.1105443
GSM549141patient 045, cancer, homogenized [OPG study]5.880656
GSM549130patient 028, cancer, homogenized [OPG study]5.2803246
GSM549101patient 111, normal, homogenized [OPG study]4.9849339
GSM549105patient 128, normal, homogenized [OPG study]5.0776141
GSM549106patient 134, normal, homogenized [OPG study]5.9832758
GSM549112patient 048, normal, homogenized [OPG study]4.723234
GSM549125patient 011, cancer, homogenized [OPG study]5.2537645
GSM549127patient 024, cancer, homogenized [OPG study]5.0599141
GSM549135patient 035, cancer, homogenized [OPG study]6.4949165